Global Liver Diseases Therapeutics Market to grow at a CAGR of 15.61% by 2019

About liver diseases

Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. The liver diseases caused by viral infections, alcoholism, obesity, diabetes, among many other reasons. Some of the diseases are not curable such as liver cirrhosis or non-alcoholic fatty liver disease, and are usually not diagnosed early. This leads to the substantial damage of the liver, which proves to be life-threatening. Some types of hepatitis are preventable or treatable by using vaccines and indicated drugs.

Technavio’s analysts forecast the global liver diseases therapeutics market to grow at a CAGR of 15.61% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global liver diseases therapeutics market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of liver diseases.

Based on disease indication, the market is segmented as follows:

Non-alcoholic fatty liver disease (includes non-alcoholic steatohepatitis)

Liver cirrhosis

Liver cancer

Hepatitis (Hepatitis A, B, and C)

This report includes a discussion of the market in the following three regions:

Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil

EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE

APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India.

Technavio’s report, Global Liver Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the global liver diseases therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/386540

Key regions

Americas

APAC

EMEA

Key vendors

Hoffmann-La Roche

Gilead Sciences

GlaxoSmithKline

Johnson & Johnson

Merck

Other prominent vendors

AbbVie

Achillion Pharmaceuticals

Advinus

Angion Biomedica

AstraZeneca

Bayer

BiOrion

Boehringer Ingelheim

Bristol-Myers Squibb

Celsion

Conatus

Digna Biotech

Dynavax Technologies

Eli Lilly

Galectin Therapeutics

Genfit

GenKyoTex

Isis Pharmaceuticals

Janssen Pharmaceuticals

Kaketsuken

La Jolla Pharmaceutical

LG Life Sciences

Mitsubishi Tanabe Pharma

Nitto Denko

Novartis

Onyx Pharmaceuticals

Phenex Pharmaceuticals

Promedior

Promethera Biosciences

ProMetic Life Sciences

Raptor Pharmaceuticals

Shenzhen Kangtai Biological Products

TCM Biotech

Tobira Therapeutics

VBL Therapeutics

Verva Pharmaceuticals

Virobay

Zafgen

Key market driver

Increased prevalence of liver diseases

For a full, detailed list, view our report

Key market challenge

Multiple patent expiries

For a full, detailed list, view our report

Key market trend

Growing public awareness

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

About Us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Latest Industry Press Release http://www.marketresearchreports.biz/pressreleases

Contact Us

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

Email: sales@marketresearchreports.biz